CN110367367A - A kind of pressed candy and preparation method thereof making one deep sleep - Google Patents
A kind of pressed candy and preparation method thereof making one deep sleep Download PDFInfo
- Publication number
- CN110367367A CN110367367A CN201910788470.1A CN201910788470A CN110367367A CN 110367367 A CN110367367 A CN 110367367A CN 201910788470 A CN201910788470 A CN 201910788470A CN 110367367 A CN110367367 A CN 110367367A
- Authority
- CN
- China
- Prior art keywords
- weight
- powder
- royal jelly
- parts
- deep sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 55
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 69
- 229940109850 royal jelly Drugs 0.000 claims abstract description 69
- 239000002994 raw material Substances 0.000 claims abstract description 31
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 13
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 10
- 229940089161 ginsenoside Drugs 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims description 19
- 241001247821 Ziziphus Species 0.000 claims description 15
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000007603 infrared drying Methods 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- 159000000003 magnesium salts Chemical class 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- -1 hydroxypropyl Chemical group 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 abstract description 15
- 239000003163 gonadal steroid hormone Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 230000004060 metabolic process Effects 0.000 abstract description 9
- 210000000056 organ Anatomy 0.000 abstract description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 4
- 230000002159 abnormal effect Effects 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 238000002156 mixing Methods 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 239000012798 spherical particle Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010013980 Dyssomnias Diseases 0.000 description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2220/00—Products with special structure
- A23G2220/20—Products with special structure with a composite structure, e.g. laminated products, coated products, microstructures, e.g. with encapsulated ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of pressed candies and preparation method thereof for making one deep sleep, be made including the following raw material: powder, royal jelly freeze-dried powder, jujube concentration powder, γ-aminobutyric acid, ginsenoside powder and auxiliary material is concentrated in semen ziziphi spinosae, pressed candy of the present invention is adjusted body system by the synergistic effect of each raw material, be conducive to the metabolism of cardiovascular and cerebrovascular, required nutrition is sufficiently fed, and mainly passes through royal jelly freeze-dried powder and γ-aminobutyric acid collective effect；The royal jelly freeze-dried powder prepared by the method for the invention can promote the generation of sex hormone, promote to enter deep sleep in the human brain short time, its hetero-organization also can comprehensively adjust the physiological function of each organ of body, taking for short time can make human body sex hormone level between the physiology phase that sex hormone declines tend to be steady, and reduce involutional abnormal phenomenon.
Description
Technical field
The invention belongs to health product technology fields, and in particular to a kind of pressed candy for making one deep sleep and its preparation side
Method.
Background technique
The one third of life is spent in sleep, and only possessing good sleep could maintain normally to live, work
And study, it may be said that sleep is to maintain the premise and basis of mankind's activities.Deep sleep be sleep a part, also by
Referred to as " gold sleep ", only accounts for the 25% of entire sleeping time.Deep sleep can alleviate people's fatigue in one day, promote people
The metabolism of body is very good to body.45-60 years old crowd can undergo a kind of week during this period of time
The sex hormone variation of phase property influences the endocrine metabolism imbalance of body, and with angiocarpy, the clinical symptoms of nervous system are main table
It is existing.General female just entered into the climacteric period at 45-55 years old, and ovulation and ischomenia lose fecundity, this is primarily due to ovum
Nest deterioration so that disappear.Involutional performance, be mainly change in menstrual cycle characteristics before menopause: the menstruation rhythm and pace of moving things changes: the period prolongs
Long, intermenstrual period does not come every extension or two, March, restores its natural law after some months again.Menopause is passed through with regular in this way
It is alternately present, one, two year can be continued.Mainly have: flush fever creeps up entire face, face since the lower part
Often there are significant blood vessel dilatation, rubescent, panhidrosis in portion.Occur dizzy, dizziness simultaneously, flush degree is different, some be limited to face,
Neck is rubescent, it is also possible to very frequent and serious.Vegetative dystonie, extremity numbness, especially in night acroparesthesia, convulsion
Contraction, lower limb are heavy, two legs seem not know this be placed on where, abdomen pain, nervous, precordial pain is headache, dizzy, insomnia and
Syncope；Often have irritable, emotional instability, it is hot-tempered, it is sometimes suspicious with it is depressed.To climacteric, male climacteric can also go out
Now similar symptom.It is all with confusion of thinking body basic quality decline of having a sleepless night.Brain worker is long-term.It sleeps abnormal,
It stays up late excessively, whole day sleepiness weak all over.Occur simultaneously with diabetes, hypertension, gout chronic diseases in addition to this.Climacteric
Phase meeting sex hormone decline, human body can generate corresponding palpitaition, general weakness, dyssomnias, and whole organ functional declines, simultaneously
Sleep quality decline, is easy to produce insomnia, it is difficult to deep sleep is carried out, to influence health.
The drug of existing treatment insomnia mainly has barbiturates, Benzodiazepines, Non-benzodiazepine, these early stages
Sedative hypnotic drug long-term use is easy to produce according to lazyness, and larger dose can cause dizzy out of strength, dispersion attention, study often
Memory capability decline, long-term administration hang-up will appear the adverse reactions such as rebound phenomenon or withrawal symptom.Many Chinese medicines improve and
There is long-term clinical application history in terms for the treatment of sleep disturbance, these Chinese Herbs are definite, and adverse reaction is small, have become people
The hot spot studied.
For these reasons, the present invention is specifically proposed.
Summary of the invention
In order to solve problem above of the existing technology, the present invention provides a kind of pressed candy for making one deep sleep and
Preparation method, pressed candy of the invention is easy to carry, using by environmental restrictions, calm nerves do not promote human body to enter depth
Sleep state is spent, the conciliation of female climacteric syndrome is additionally aided.
To achieve the goals above, the present invention adopts the following technical scheme:
A kind of pressed candy making one deep sleep, including the following raw material are made: semen ziziphi spinosae be concentrated powder, royal jelly freeze-dried powder,
Powder, γ-aminobutyric acid, ginsenoside powder and auxiliary material is concentrated in jujube.
Further, be made according to parts by weight, including the following raw material: powder 2100-2500 parts by weight, queen bee are concentrated in semen ziziphi spinosae
Starch freeze-dried powder 1500-1700 parts by weight, powder 900-1000 parts by weight, γ-aminobutyric acid 55-71 parts by weight, ginseng are concentrated in jujube
Stem leaf saponin powder 250-350 parts by weight and auxiliary material 2700-2900 parts by weight.
Further, be made according to parts by weight, including the following raw material: 2288 parts by weight of powder are concentrated in semen ziziphi spinosae, royal jelly freezes
950 parts by weight of powder, 63 parts by weight of γ-aminobutyric acid, 300 weight of ginsenoside powder are concentrated in 1600 parts by weight of dry powder, jujube
Part and 2800 parts by weight of auxiliary material.
Semen ziziphi spinosae has significant calm and syngignoscism and anticonvulsant action in semen ziziphi spinosae concentration powder.To cardiovascular system
There is significant protective effect, semen ziziphi spinosae aqueous extract has apparent anti-inflammatory effect, mitigates ischemic brain damage.
Jujube be concentrated powder have blood pressure lowering, norcholesterol, adjust body metabolism, strengthen immunity, anti-inflammatory, resistance state is anti-
It answers, reduce the effects of blood glucose and cholesterol level；Contained rutin have protection capillary it is unobstructed, prevent vascular wall brittleness increase.
Jujube can improve the phagocytic function of internal monocyte, play the role of protecting liver, enhancing physical strength；Vitamin C in jujube, energy
Mitigate damage of the chemicals to liver, and have and promote protein synthesis, increases the effect of the Total albumen content.To prevention and treatment bone
Matter is loose, anaemia plays an important role, middle-aged and the old's climacteric often osteoporosis, be growing development peak teenager and
Women is easy to happen anaemia, and jujube has very ideal dietary function to them, and effect is usually that drug cannot compare.
To perfecting capillary, maintaining vessel wall elasticity, antiatherosclerosis is very beneficial；It shows as improving microcirculation in human body, expansion
Coronary artery increases the amount of blood supply of brain and heart, and decreasing heart rate reduces myocardial oxygen consumption and improves the metabolism of ischemic myocardium, therefore
Cardiovascular and cerebrovascular diseases can be prevented and treated.Jujube can improve the immunity of the human body, and can inhibit cancer cell.It can promote the generation of leucocyte, reduce blood
Clearing gallbladder sterol improves seralbumin, protects liver, also containing inhibiting cancer cell in jujube, or even cancer cell can be made to normal
The substance of cell transformation.
γ-aminobutyric acid is inhibitory neurotransmitter critically important in central nervous system, it is a kind of naturally occurring
Non-protein forms amino acid, has extremely important physiological function, it can promote the reactivity of brain, brain tonic and intelligence development, and anti-epileptic promotees
Into sleep, beauty moisturizing delays brain aging function, can supplement human body inhibitory neurotransmitter, has good blood pressure reduction effect.
Promote kidney Fitness improvement and protective effect.
Ginsenoside powder stem and leaf of Radix Ginseng saponin can obviously inhibit lipid peroxide in brain and liver to be formed, and reduce brain
The content of lipofuscin in cortex and liver；Stem and leaf of Radix Ginseng saponin has antioxidation, and stem and leaf of Radix Ginseng saponin, which has, stablizes membrane structure
With increase protein synthesis, memory of the elder ability can be improved.
Further, the auxiliary material is hydroxypropyl methyl cellulose, polyvinyl alcohol, stearic acid, microcrystalline cellulose and difficulty
Dissolubility calcium salt or magnesium salts.
Further, according to parts by weight, the auxiliary material is hydroxypropyl methyl cellulose 15-20 parts by weight, polyvinyl alcohol
2-5 parts by weight, stearic acid 2-5 parts by weight, microcrystalline cellulose 10-35 parts by weight and slightly solubility calcium salt or magnesium salts 0-5 parts by weight.
Further, the royal jelly freeze-dried powder is prepared by the following method:
(1) aqueous solution for the mannitol that the concentration of equivalent is 10% will be added in royal jelly, stir evenly, cross 120 meshes
Processing；
(2) royal jelly of filtering is fitted into pallet, royal jelly with a thickness of 8-10mm, be freeze-dried；
(3) it is rapidly frozen royal jelly at being -45~-40 DEG C in temperature, keeps royal jelly in the case where vacuum degree is 9-11mmg
At a temperature of -23~-27 DEG C, condenser temperature is -48~-52 DEG C, and low temperature is 12-16 hours dry for the first time, by dry room temperature
Degree control carries out second of drying at 25-40 DEG C, and second of drying time is 7-10 hours, crushed the processing of 70-90 mesh, envelope
Dress obtains the royal jelly freeze-dried powder.
Further, the moisture content in step (3) after drying for the first time in royal jelly is reduced to 7-9%.
Further, the moisture content after second of drying of step (3) in royal jelly is down to 1.5-2.5%.
Royal jelly freeze-dried powder of the invention is prepared by specific preparation condition, not only makes the shelf-life of royal jelly
Extend, and also improves the content of the effective component DHA in royal jelly, and make in manufactured pressed candy in DHA
It is stabilized, it is not easy to be influenced by external environment.DHA is one of the brain development of people, the important substance of growth, is also simultaneously
A kind of Major Nutrient substance nervous system cell growth and maintained, is the important composition ingredient of brain and retina, in human body
Content is up to 20% in cerebral cortex, and proportion is maximum in eye retina, accounts for about 50%, to tire infant intelligence and eyesight
It develops most important.
Royal jelly freeze-dried powder has the patient of obvious old symptom or even the declining years critically ill patient's good effect worn with age
Elderly patient, in the case where conventional medication is ineffective, taking royal jelly freeze-dried powder can pull through.For prolonged illness body
The patient to decline has apparent improvement using royal jelly freeze-dried powder, and rehabilitation is quickly.The two-way adjustment of royal jelly freeze-dried powder acts on,
It is the blood pressure of hypertensive patient can be down to normally less than all drug, and settles out, it also can be by hypotensive
Blood pressure rise to normally, can also settle out；Royal jelly freeze-dried powder has corrective action to cardiovascular system, treats coronary heart disease, brain
The disease of cardiovascular systems such as thrombus, cerebral embolism, hypertension, low blood pressure, can play the role of conventional medicine be difficult to play it is peculiar；Bee
Royal jelly freeze-dried powder is effective to various rheumatism and other disease of immune system；In clinic, taking royal jelly freeze-dried powder makes very much
The woman in menstrual period of too early amenorrhoea has restored that the patient for much losing sexual function is normally made to have restored sexual function.Royal jelly freeze-dried powder
It is obvious to the patient outcomes of diabetic and other endocrine disorders；No matter to internal injury, outer wound, royal jelly freeze-dried powder energy
Enhancing metabolism promotes histocyte regeneration.Royal jelly freeze-dried powder can make lath sturdy, and fat people can also be made to lose weight；Simultaneously also
Has the function of anticancer；The damage caused by radiation and chemotherapy has protective action；It can prevent and treat and be mixed caused by noise on human body function
Disorderly.
A kind of preparation method of the pressed candy making one deep sleep, includes the following steps:
(a) it is weighed respectively according to the weight of each raw material spare；
(b) each raw material is uniformly mixed, is successively pelletized, dried, tabletting, is coated, dries in the air piece, packaging.
Further, the processing of 8-12 mesh is crossed in step (b) after granulation.
Further, it is 45-55 DEG C of infra-red drying that step (b) is dry.
Annular sulfided state is presented after each raw material is mixed in container (fluidized bed), is heated air by after purification
The alcohol that binder is concentration 90% is atomized and sprays into, makes several particle buildups at the granule containing binder by preheating and mixing,
Continuous drying due to hot-air to material evaporates moisture in granule, and adhesive, this process constantly repeats, shape
At uniform more micropore spherical particles.
Every 800 milligrams of pressed candy net content of the invention, the first two hour swallows 3-5 piece, warm cold water just before going to bed daily
It send down.It is general to require to prepare to fall asleep between 22:30 to 23 points according to everyone different sleep habits.5-30 minutes, mostly
Number people can enter deep sleep.It is counted according to clinical test.It is left up to 4-5 hour to take pressed candy deep sleep of the invention
It is right.Sleep has been basically completed the physiology course of everyone cerebral metabolism for the first time.Brain memory is clear after 3 points of morning revivals, thinks
Dimension is quick, feels salubrious.Enter after having a short interval second and sleep, mainly the fatigue of recovery body physical strength, about three
Or so a hour, body completely eliminates fatigue state.Compared with prior art, the invention has the benefit that
(1) pressed candy of the present invention is adjusted body system by the synergistic effect of each raw material, is conducive to heart and brain blood
The metabolism of pipe, required nutrition are sufficiently fed, and mainly pass through royal jelly freeze-dried powder and γ-aminobutyric acid collective effect；
It is largely to be generated by sex hormone, therefore work as according to each hebetic physiological performance motive power of the principle human body of biological rhythm
Human body will generate corresponding palpitaition, general weakness, dyssomnias, whole organ functional when climacteric sex hormone declines
Decline, royal jelly freeze-dried powder prepared by the method for the present invention can promote the generation of sex hormone, promote human brain in short-term
Interior to enter deep sleep, hetero-organization also can comprehensively adjust the physiological function of each organ of body, and the short time takes energy
So that human body sex hormone level during the physiology that sex hormone declines is tended to be steady, reduces involutional abnormal phenomenon；According to
Clinical test statistics takes pressed candy deep sleep of the invention up to four hours, and sleep has been basically completed everyone brain
The physiology course of metabolism；
(2) all selection integration of drinking and medicinal herbs food is accurately selected raw material of the invention using biology extraction scientific technology
There is the Related Component of corrective action for human body, do not add any chemical additives, complies fully with the standard of food；
(3) preparation method of pressed candy of the present invention uses dry granulation, water is not added in whole preparation process, by auxiliary
Expect the collective effect between major ingredient, between each raw material be easier to that grain is made, so that when the disintegration of the pressure candy of preparation
Between accelerate, and then absorption rate is fast.
Specific embodiment
To make the object, technical solutions and advantages of the present invention clearer, technical solution of the present invention will be carried out below
Detailed description.Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Base
Embodiment in the present invention, those of ordinary skill in the art are obtained all without making creative work
Other embodiment belongs to the range that the present invention is protected.
The manufacturer that powder is concentrated in semen ziziphi spinosae described in the embodiment of the present invention is Nanjing Ze Lang Biotechnology Co., Ltd.
Embodiment 1
A kind of pressed candy making one deep sleep of the present embodiment, including the following raw material are made: powder is concentrated in semen ziziphi spinosae
2100g, royal jelly freeze-dried powder 1500g, jujube concentration powder 900g, γ-aminobutyric acid 55g, ginsenoside powder 250g and auxiliary
Expect 2700g, wherein the auxiliary material according to the raw material of following parts by weight for being made: 15 parts by weight of hydroxypropyl methyl cellulose are gathered
2 parts by weight of vinyl alcohol, 2 parts by weight of stearic acid, 10 parts by weight of microcrystalline cellulose；
Wherein, the royal jelly freeze-dried powder the preparation method is as follows:
(1) aqueous solution for the mannitol that the concentration of equivalent is 10% will be added in royal jelly, stir evenly, cross 120 meshes
Processing；
(2) royal jelly of filtering is fitted into pallet, royal jelly with a thickness of 8-10mm, be freeze-dried；
(3) it is rapidly frozen royal jelly at being -45 DEG C in temperature, so that royal jelly is maintained at -23 DEG C in the case where vacuum degree is 9mmg
At a temperature of, condenser temperature is -48 DEG C, and low temperature is 12 hours dry for the first time, for the first time the moisture content after drying in royal jelly
It is reduced to 9%, dry room temperature control is subjected to second of drying at 25 DEG C, second of drying time is 7 hours, and second dry
Moisture content after dry in royal jelly is down to 2.5%, crushed the processing of 70 meshes, and encapsulation obtains the royal jelly freeze-dried powder.
The pressed candy for making one deep sleep of the present embodiment the preparation method is as follows:
(a) it is weighed respectively according to the weight of each raw material spare；
(b) each raw material is uniformly mixed, is successively pelletized, crosses the processing of 8 meshes, infra-red drying, tabletting, packet at 45 DEG C
Clothing, dry in the air piece, packaging.
Wherein, annular sulfided state will be presented in container (fluidized bed) after the mixing of each raw material, is added by after purification
The alcohol that binder is concentration 90% is atomized and sprays into, makes several particle buildups at containing binder by hot-air preheating and mixing
Granule, the continuous drying due to hot-air to material evaporates moisture, and adhesive, this process constantly repeats
It carries out, forms uniform more micropore spherical particles, granulation is completed.
Embodiment 2
A kind of pressed candy making one deep sleep of the present embodiment, including the following raw material are made: powder is concentrated in semen ziziphi spinosae
2288g, royal jelly freeze-dried powder 1600g, jujube concentration powder 950g, γ-aminobutyric acid 63g, ginsenoside powder 300g and auxiliary
Expect 2800g, wherein the auxiliary material according to the raw material of following parts by weight by being made: 17.5 parts by weight of hydroxypropyl methyl cellulose,
3.5 parts by weight of polyvinyl alcohol, 3.5 parts by weight of stearic acid, 22.5 parts by weight of microcrystalline cellulose, 2.5 parts by weight of calcium carbonate；
Wherein, the royal jelly freeze-dried powder the preparation method is as follows:
(1) aqueous solution for the mannitol that the concentration of equivalent is 10% will be added in royal jelly, stir evenly, cross 120 meshes
Processing；
(2) royal jelly of filtering is fitted into pallet, royal jelly with a thickness of 8-10mm, be freeze-dried；
(3) it is rapidly frozen royal jelly at being -42.5 DEG C in temperature, so that royal jelly is maintained at -25 in the case where vacuum degree is 10mmg
At a temperature of DEG C, condenser temperature is -50 DEG C, and low temperature is 14 hours dry for the first time, and the moisture after drying in royal jelly contains for the first time
Amount is reduced to 8%, and dry room temperature control is dry for the second time in 37.5 DEG C of progress, and second of drying time is 8.5 hours, the
Moisture content after redrying in royal jelly is down to 2%, crushed the processing of 80 meshes, and encapsulation obtains the royal jelly and freezes
Dry powder.
The pressed candy for making one deep sleep of the present embodiment the preparation method is as follows:
(a) it is weighed respectively according to the weight of each raw material spare；
(b) each raw material is uniformly mixed, successively pelletized, cross 10 meshes processing, at 50 DEG C infra-red drying, tabletting,
It is coated, dry in the air piece, packaging.
Wherein, annular sulfided state will be presented in container (fluidized bed) after the mixing of each raw material, is added by after purification
The alcohol that binder is concentration 90% is atomized and sprays into, makes several particle buildups at containing binder by hot-air preheating and mixing
Granule, the continuous drying due to hot-air to material evaporates moisture, and adhesive, this process constantly repeats
It carries out, forms uniform more micropore spherical particles, granulation is completed.
Embodiment 3
A kind of pressed candy making one deep sleep of the present embodiment, including the following raw material are made: powder is concentrated in semen ziziphi spinosae
2500g, royal jelly freeze-dried powder 1700g, jujube concentration powder 1000g, γ-aminobutyric acid 71g, ginsenoside powder 350g and auxiliary
Expect 2900g, wherein the auxiliary material according to the raw material of following parts by weight for being made: 20 parts by weight of hydroxypropyl methyl cellulose are gathered
5 parts by weight of vinyl alcohol, 5 parts by weight of stearic acid, 35 parts by weight of microcrystalline cellulose, 5 parts by weight of magnesium carbonate；
Wherein, the royal jelly freeze-dried powder the preparation method is as follows:
(1) aqueous solution for the mannitol that the concentration of equivalent is 10% will be added in royal jelly, stir evenly, cross 120 meshes
Processing；
(2) royal jelly of filtering is fitted into pallet, royal jelly with a thickness of 8-10mm, be freeze-dried；
(3) it is rapidly frozen royal jelly at being -40 DEG C in temperature, so that royal jelly is maintained at -27 DEG C in the case where vacuum degree is 11mmg
At a temperature of, condenser temperature is -52 DEG C, and low temperature is 16 hours dry for the first time, for the first time the moisture content after drying in royal jelly
It is reduced to 7%, dry room temperature control is subjected to second of drying at 40 DEG C, second of drying time is 10 hours, second
Moisture content after drying in royal jelly is down to 1.5%, crushed the processing of 90 meshes, and encapsulation obtains the royal jelly freeze-drying
Powder.
The pressed candy for making one deep sleep of the present embodiment the preparation method is as follows:
(a) it is weighed respectively according to the weight of each raw material spare；
(b) each raw material is uniformly mixed, successively pelletized, cross 12 meshes processing, at 55 DEG C infra-red drying, tabletting,
It is coated, dry in the air piece, packaging.
Wherein, annular sulfided state will be presented in container (fluidized bed) after the mixing of each raw material, is added by after purification
The alcohol that binder is concentration 90% is atomized and sprays into, makes several particle buildups at containing binder by hot-air preheating and mixing
Granule, the continuous drying due to hot-air to material evaporates moisture, and adhesive, this process constantly repeats
It carries out, forms uniform more micropore spherical particles, granulation is completed.
Test example 1
Slaking test is carried out to the pressed candy of embodiment 1-3 preparation respectively, disintegration time is measured, the results are shown in Table 1.
Table 1
| Group | Disintegration time (min) |
| Embodiment 1 | 25 |
| Embodiment 2 | 23 |
| Embodiment 3 | 24 |
As can be seen from the above table, pressed candy disintegration time prepared by the present invention is no more than 25min and all dissolves, and illustrates this
The pressed candy human body of invention preparation is easy to absorb after taking.
Case 1
Mr. Li, male, 35 years old, the long-term late into the night work of press editor to morning, habituation insomnia, appearance Asia in poor health
Health status.Please doctor, nutritionist suggest use the product, overdue three months.Daily 21 points of evening takes the pressure of the preparation of embodiment 1
Piece candy 4, after about two hours, prepare sleep.Enter sleep state within 15 minutes or so.First stage deep sleep about four
Brains is clear after a hour wake up, and eyesight understands, closes the eyes for rest, slightly suitable rest about 40 minutes.Gradually it is slept into second stage
It sleeps, about three hours wake up naturally.Antisecosis is good, energetic.After taking three months, life is returned to normal
Reason state.
Case 2
Liu, female, 53 years old, individual enterprise president, general manager.Operating pressure is big, worries beyond measure, and is in climacteric, there is the phase
There is illusion in the performance palpitaition of comprehensive card, hypertension, hyperglycemia, insomnia, thinking.Influence normal life and work.It is built through doctor
View takes product normal physiological condition after restoring climacteric, two to three hours after daily supper, according to body for a long time
The physiological status of different cycles.Pressed candy three to five for taking the preparation of embodiment 2, can be interrupted use.From when preparing sleep
Between start, about half an hour enters first stage deep sleep, this indoor and outdoor moderate sound, illumination is reactionless, indoors three meters it
Interior to talk with other people, by the deep sleep of about five hours, conscious, coordination can be slightly living indoors
It is dynamic.Enter second stage after quiet rest of lying to regain one's strength until naturally waking up, by adjustment in six months, basic restore just of sleeping
Often, blood pressure and blood sugar is all declined, and substantially restores normal work and life state.
Case 3
Sun, female, 20 years old, graduating college entrance examination graduate, diligent senior middle school's study, reading daily in nearly 2 years to the late into the night, length
Time sleep is among illusion, bad resting state, causes physical fatigue, memory extremely decline school grade is significantly
Decline.Nutrient health Shi Jianyi takes this product.The first two hour takes pressed candy 3- prepared with embodiment 3 just before going to bed every night
4.Prepare sleep to start to call reactionless, slow movement, the not performance of dream up to deep sleep five to ten minutes.First
Stage sleep is generally in five hours, after regaining consciousness.Short time enters second stage and sleeps about two hours, this stage is to the external world
The sound, illumination is more sensitive, energetic after eliminating fatigue, is swift in motion, arrangement of getting up.It, should by adjustment in one month
Student performance is gradually increasing, and hypermnesia, college entrance examination easily obtains good result.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any
Those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, and should all contain
Lid is within protection scope of the present invention.Therefore, protection scope of the present invention should be based on the protection scope of the described claims.
Claims (10)
1. a kind of pressed candy for making one deep sleep, which is characterized in that be made including the following raw material: powder, queen bee is concentrated in semen ziziphi spinosae
Starch freeze-dried powder, jujube concentration powder, γ-aminobutyric acid, ginsenoside powder and auxiliary material.
2. the pressed candy according to claim 1 for making one deep sleep, which is characterized in that according to parts by weight, including it is as follows
Raw material is made: semen ziziphi spinosae is concentrated powder 2100-2500 parts by weight, royal jelly freeze-dried powder 1500-1700 parts by weight, jujube and powder is concentrated
900-1000 parts by weight, γ-aminobutyric acid 55-71 parts by weight, ginsenoside powder 250-350 parts by weight and auxiliary material 2700-
2900 parts by weight.
3. the pressed candy according to claim 2 for making one deep sleep, which is characterized in that according to parts by weight, including it is as follows
Raw material is made: semen ziziphi spinosae be concentrated 2288 parts by weight of powder, 1600 parts by weight of royal jelly freeze-dried powder, jujube concentration 950 parts by weight of powder,
2800 parts by weight of 63 parts by weight of γ-aminobutyric acid, 300 parts by weight of ginsenoside powder and auxiliary material.
4. the pressed candy according to claim 1 for making one deep sleep, which is characterized in that the auxiliary material is hydroxypropyl first
Base cellulose, polyvinyl alcohol, stearic acid, microcrystalline cellulose and slightly solubility calcium salt or magnesium salts.
5. the pressed candy according to any one of claims 1-4 for making one deep sleep, which is characterized in that the queen bee
Slurry freeze-dried powder is prepared by the following method:
(1) aqueous solution for the mannitol that the concentration of equivalent is 10% will be added in royal jelly, stir evenly, cross the processing of 120 meshes；
(2) royal jelly of filtering is fitted into pallet, royal jelly with a thickness of 8-10mm, be freeze-dried；
(3) temperature be -45~-40 DEG C at be rapidly frozen royal jelly, vacuum degree be 9-11mmg under make royal jelly be maintained at -
At a temperature of 23~-27 DEG C, condenser temperature is -48~-52 DEG C, and low temperature is 12-16 hours dry for the first time, by dry room temperature control
For system in second of drying of 25-40 DEG C of progress, second of drying time is 7-10 hours, crushed the processing of 70-90 mesh, encapsulates,
Obtain the royal jelly freeze-dried powder.
6. the pressed candy according to claim 5 for making one deep sleep, which is characterized in that dry for the first time in step (3)
The moisture content in royal jelly is reduced to 7-9% afterwards.
7. the pressed candy according to claim 5 for making one deep sleep, which is characterized in that after second of step (3) dry
Moisture content in royal jelly is down to 1.5-2.5%.
8. making one the preparation method of the pressed candy of deep sleep described in a kind of claim 1-7 any one, which is characterized in that
Include the following steps:
(a) it is weighed respectively according to the weight of each raw material spare；
(b) each raw material is uniformly mixed, is successively pelletized, dried, tabletting, is coated, dries in the air piece, packaging.
9. the preparation method of the pressed candy according to claim 8 for making one deep sleep, which is characterized in that in step (b)
The processing of 8-12 mesh is crossed after granulation.
10. the preparation method of the pressed candy according to claim 8 for making one deep sleep, which is characterized in that step (b) is dry
Dry is 45-55 DEG C of infra-red drying.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910788470.1A CN110367367A (en) | 2019-08-26 | 2019-08-26 | A kind of pressed candy and preparation method thereof making one deep sleep |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910788470.1A CN110367367A (en) | 2019-08-26 | 2019-08-26 | A kind of pressed candy and preparation method thereof making one deep sleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110367367A true CN110367367A (en) | 2019-10-25 |
Family
ID=68260671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910788470.1A Pending CN110367367A (en) | 2019-08-26 | 2019-08-26 | A kind of pressed candy and preparation method thereof making one deep sleep |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110367367A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110973326A (en) * | 2019-12-11 | 2020-04-10 | 刘玉华 | Tabletting candy capable of improving sub-health of human body and preparation method thereof |
| CN115152882A (en) * | 2022-07-25 | 2022-10-11 | 新疆疆多宝健康科技有限公司 | Camel milk and royal jelly collagen peptide composite tablet candy and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1651021A (en) * | 2004-12-06 | 2005-08-10 | 辽宁大生药业有限公司 | Ginseng royal jelly soft capsule and its preparation process |
| CN102302108A (en) * | 2011-07-10 | 2012-01-04 | 荆门市顺昌蜂业有限公司 | Pure royal jelly tablet machining process |
| CN102524624A (en) * | 2012-01-19 | 2012-07-04 | 湖南明园蜂业科技有限公司 | Bee product with function of improving sleeping and preparation method thereof |
| CN102793733A (en) * | 2012-08-27 | 2012-11-28 | 湖南华纳大药厂有限公司 | Ginseng royal jelly chewable tablets and preparation method thereof |
| CN106070958A (en) * | 2016-07-06 | 2016-11-09 | 慧谷生命科技湖北有限公司 | A kind of gamma aminobutyric acid sheet and preparation method thereof |
| CN108651669A (en) * | 2018-03-14 | 2018-10-16 | 新疆中农坤源生物科技有限公司 | Sea-buckthorn royal jelly freeze-dried powder pressed candy |
-
2019
- 2019-08-26 CN CN201910788470.1A patent/CN110367367A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1651021A (en) * | 2004-12-06 | 2005-08-10 | 辽宁大生药业有限公司 | Ginseng royal jelly soft capsule and its preparation process |
| CN102302108A (en) * | 2011-07-10 | 2012-01-04 | 荆门市顺昌蜂业有限公司 | Pure royal jelly tablet machining process |
| CN102524624A (en) * | 2012-01-19 | 2012-07-04 | 湖南明园蜂业科技有限公司 | Bee product with function of improving sleeping and preparation method thereof |
| CN102793733A (en) * | 2012-08-27 | 2012-11-28 | 湖南华纳大药厂有限公司 | Ginseng royal jelly chewable tablets and preparation method thereof |
| CN106070958A (en) * | 2016-07-06 | 2016-11-09 | 慧谷生命科技湖北有限公司 | A kind of gamma aminobutyric acid sheet and preparation method thereof |
| CN108651669A (en) * | 2018-03-14 | 2018-10-16 | 新疆中农坤源生物科技有限公司 | Sea-buckthorn royal jelly freeze-dried powder pressed candy |
Non-Patent Citations (2)
| Title |
|---|
| 曹炜，等: "《蜂产品深加工技术》", 30 April 2011, 中国轻工业出版社 * |
| 李旭涛，等: "蜂王浆品质优化系列新产品的研究", 《中国蜂业》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110973326A (en) * | 2019-12-11 | 2020-04-10 | 刘玉华 | Tabletting candy capable of improving sub-health of human body and preparation method thereof |
| CN115152882A (en) * | 2022-07-25 | 2022-10-11 | 新疆疆多宝健康科技有限公司 | Camel milk and royal jelly collagen peptide composite tablet candy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7645462B2 (en) | Acupoint patch | |
| Březinová et al. | Sleep after a bedtime beverage | |
| CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
| CN110367367A (en) | A kind of pressed candy and preparation method thereof making one deep sleep | |
| CN102920806B (en) | Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea | |
| CN103719493A (en) | Brain-boosting and intelligence-enhancing sealwort health-care tea and preparation method thereof | |
| CN101152239A (en) | Technique of preparing drone pupa freeze-dried powder medicinal granules and capsule | |
| CN1109554C (en) | Medicine for treating allergic purpura | |
| CN109077321A (en) | A kind of composition and preparation method thereof with strengthen immunity and antioxidation | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN102727761A (en) | Medicine for treating alopecia seborrheica and preventing hair drying and bifurcating and method for preparing medicine | |
| CN107468931A (en) | A kind of blood-pressure decreasing tea and preparation method thereof | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN109833381A (en) | A kind of pure plant drug composition improving sleep | |
| CN108478714A (en) | A kind of paediatrics self-closing disease rehabilitation auxiliary Chinese medicine composition | |
| CN104432052A (en) | Health capsules capable of resisting fatigue and preventing aging and preparation method thereof | |
| CN1142785C (en) | Antifatigue capsule | |
| CN106822660A (en) | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease | |
| CN104256618B (en) | A kind of hypoglycemic food, health products or pharmaceutical composition | |
| CN107050143A (en) | It is a kind of that there is the formula for improving sleep effect, composition and preparation method thereof | |
| CN103202964B (en) | Brain-improving and mind-calming medicinal liquor | |
| CN107875256B (en) | Zhuang-medicine acupoint application plaster for treating insomnia and manufacturing method thereof | |
| CN102973687B (en) | Oral liquid for regulating female hormonal balance | |
| CN100488519C (en) | Medicine for treating dysmenorrhea and its preparing method | |
| CN106039172B (en) | There is the Chinese medicine composition for improving memory function and its application containing centella |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191025 |